39 results
DEFA14A
AUPH
Aurinia Pharmaceuticals Inc
3 Jun 24
Additional proxy soliciting materials
6:28pm
, such that his or her employment or engagement has been frustrated. For purposes of Incentive Stock Options, “Disability” shall mean a “permanent and total
8-K
EX-99.1
AUPH
Aurinia Pharmaceuticals Inc
2 May 24
Aurinia Pharmaceuticals Reports First Quarter 2024 Financial and Operational Results
6:03am
barriers to care among LN patients, (Diversity, Equity and Inclusion) DE&I practices, employee engagement, and risk management. The full report is available
DEFA14A
sv56b0zsy1692jotxd
18 Apr 22
Additional proxy soliciting materials
7:36am
S-8
EX-10.1
inljlcuzx1j
25 Jun 21
Registration of securities for employees
4:31pm
8-K
EX-99.1
4qxfet8 bzmgubmci0
10 Jun 21
Departure of Directors or Certain Officers
4:08pm
DEF 14A
5h21otwq
10 May 21
Definitive proxy
4:06pm
PRE 14A
84z o6mszfm
27 Apr 21
Preliminary proxy
4:32pm
8-K
EX-3.2
fj6tautcv0uq u46yby
27 Apr 21
Amendments to Articles of Incorporation or Bylaws
4:17pm
10-K
EX-10.17
hwci vxijl7itvh2p
24 Feb 21
Annual report
4:09pm
8-K
EX-99.2
8slu8 x8tdnc
25 Jan 21
Financial Statements and Exhibits
8:21am
8-K
EX-99.1
sgywcmti298
25 Jan 21
Financial Statements and Exhibits
8:21am
6-K
EX-99.2
d93yatzgc2vee m0xszt
30 Dec 20
Material Change Report
5:30pm
6-K
EX-99.1
2aaux p53jh9
14 Oct 20
Aurinia Pharmaceuticals Inc. 6-K
6:10am
6-K
EX-99.1
2iew2qjg5cz5nnpu4h
11 Aug 20
Aurinia Pharmaceuticals Inc. 6-K
4:02pm